Core Laboratories Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $519.2M-0.9% YoYTTM through 30 Jun 2026
Net Income $24.4M-22.4% YoYTTM through 30 Jun 2026
Free Cash Flow $15.1MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 20.7% |
| EBITDA Margin | 12.1% |
| Operating Margin | 10.7% |
| Net Margin | 4.7% |
Returns
11.1%ROE
5.2%ROA
9.7%ROIC
Balance Sheet Health
Debt / Equity0.41x
Current Ratio2.02x
Net Debt$90.2M
Cash & Equivalents$22.7M
Quality Metrics
Altman Z-Score2.77
Piotroski F-Score6 / 9
FCF Margin2.9%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $526.5M
Diluted EPS$0.52TTMFY2025: $0.63
Dividend
$0.02Per share, FY20260.18%Yield-12.9%5-yr growth
Capital Allocation
Capex Intensity2.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Reservoir Description | $347.7M | +0.5% | View detailsClosely correlated with trends in international and offshore activity levels. Steady activity expected across committed long-cycle projects. |
| Production Enhancement | $178.8M | +0.6% | View detailsFocused on complex completions in unconventional oil and gas reservoirs in the U.S. and global projects. Subject to short-cycle U.S. land activity fluctuations. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.